CD163 and neoplasm: Benign adenomas (CRA) showed signs of being locked in a battle between pro- versus anti-inflammatory cells, as tumor cells clustered with cytotoxic T cells and macrophages, which in turn clustered with both anti-tumor M1 (iNOS) and pro-tumor M2 (CD163) macrophage markers (cluster 3-4 in Fig. 7c).